Doctor profile · Federal record
Dr. Sarah Nakib, MD, MPH
Dermatology Physician (CMS: Dermatology) · Baltimore, MD
- NPI 1013100049
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 19 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
601 N Caroline St
Baltimore, MD 212870006
(410) 955-8662 - Mailing address
-
Po Box 64252
Baltimore, MD 212644252
Credentials & registration
- NPI registered
- August 2007 — 19 yrs on file
- Profile last updated
- March 1, 2013
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Maryland #D74548
- Medicaid
- MD #056886400
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1013100049. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,363
Distinct HCPCS
10
Medicare allowed
$177,345
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,766 | 217 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 368 | 246 | $101 | |
17000 |
Destruction of precancer skin growth, 1 growth | 353 | 229 | $55 | |
17110 |
Destruction of skin growth, 1-14 growths | 198 | 152 | $133 | |
11102 |
Biopsy of related skin growth, first growth | 194 | 152 | $102 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 137 | 106 | $143 | |
11103 |
Biopsy of related skin growth, each additional growth | 103 | 62 | $59 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 85 | 54 | $198 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 67 | 67 | $126 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 46 | 41 | $64 |
In context: peer comparison
Among 16 peers in this city , average services per provider: 137. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$1,336
Transactions
52
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 14 | $378.50 | |
| ABBVIE INC. | 7 | $254.97 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $113.27 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $104.14 | |
| PFIZER INC. | 3 | $82.36 | |
| Amgen Inc. | 3 | $74.10 | |
| Incyte Corporation | 3 | $65.73 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $54.81 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $51.02 | |
| Galderma Laboratories, L.P. | 2 | $37.20 | |
| Dermavant Sciences, Inc. | 2 | $34.76 | |
| Novartis Pharmaceuticals Corporation | 1 | $26.53 | |
| Verrica Pharmaceuticals Inc. | 1 | $20.66 | |
| Lilly USA, LLC | 1 | $20.08 | |
| Arcutis Biotherapeutics, Inc. | 1 | $17.66 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
250
Patients
152
Total drug cost
$8,888
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 58 | 42 | $616 |
| Triamcinolone Acetonide | Generic | 55 | 41 | $341 |
| Clobetasol Propionate | Generic | 54 | 31 | $2,737 |
| Desonide | Generic | 20 | 15 | $521 |
| Metronidazole | Generic | 14 | 12 | $894 |
| Tacrolimus | Generic | 13 | 0 | $2,709 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 13 | 0 | $601 |
| Doxycycline Monohydrate | Generic | 12 | 0 | $385 |
| Mupirocin | Generic | 11 | 11 | $83 |
Frequently asked questions
What is Dr. Sarah Nakib's medical specialty?
Dr. Sarah Nakib practices Dermatology Physician in Baltimore, MD.
Where does Dr. Sarah Nakib practice?
Dr. Sarah Nakib practices at 601 N Caroline St, Baltimore, MD 212870006. Office phone: 4109558662.
What is Dr. Sarah Nakib's NPI?
Dr. Sarah Nakib's National Provider Identifier (NPI) is 1013100049, issued by NPPES.
Does Dr. Sarah Nakib accept Medicare assignment?
Yes. Dr. Sarah Nakib accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sarah Nakib commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.